Physician Profile
Marshall S. Bedine, M.D. practices gastroenterology in Lutherville, MD. Marshall is a 1967 graduate of Boston University School of Medicine. Marshall is also listed as specializing in specialist. According to Medicare claims data, Marshall cared for 1,237 Medicare patients across 29,475 services. The services billed most often include injection, vedolizumab, intravenous, 1 mg, injection, infliximab, excludes biosimilar, 10 mg, and injection, denosumab, 1 mg.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it.
Source: NPPES NPI Registry
10751 FALLS RD SUITE 301
Lutherville, MD 21093
Within Gastroenterology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Biliary and pancreas
Colon and anorectal
Esophagus and swallowing
Functional bowel and motility
Liver
Stomach and duodenum
Bowel & Colon
Digestive Symptoms
Gallbladder & Bile Ducts
Most searched procedures
Lower endoscopy
Upper endoscopy
Capsule and physiology testing
Diagnostic Testing
Liver procedures
Treatments
29,475 services · 1,237 patients · 19 distinct codes
| Procedure | Type | Code | Services |
|---|---|---|---|
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
212 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Treatment | 96365 |
110 |
| Administration of chemotherapy into vein, each additional hour | Treatment | 96415 |
91 |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
42 |
| Injection, vedolizumab, intravenous, 1 mg | Drug given | J3380 |
21,900 |
| Injection, infliximab, excludes biosimilar, 10 mg | Drug given | J1745 |
3,260 |
| Injection, denosumab, 1 mg | Drug given | J0897 |
2,520 |
| Injection, zoledronic acid, 1 mg | Drug given | J3489 |
375 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | Office visit | 99214 |
262 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | Office visit | 99213 |
222 |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Marshall S. Bedine is a gastroenterologist in Lutherville, MD. That is the designation recorded for this NPI in the federal registry, where it is listed as “Gastroenterology”.
NPI registry
Marshall S. Bedine is listed at 10751 Falls Rd Suite 301, Lutherville, MD 21093. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (410) 583-2633. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
Marshall S. Bedine's National Provider Identifier is 1194719658. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Marshall S. Bedine attended Boston University School of Medicine, graduating in 1967. This comes from the CMS National Downloadable File.
CMS public data
Marshall S. Bedine has 59 years experience. Calculated from a graduation year of 1967, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Marshall S. Bedine provides treatments such as administration of chemotherapy into vein, 1 hour or less and infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Marshall S. Bedine. If this is you, claiming it is free.
Guide.md
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.